Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lipids anticoagulant

Ischemic stroke Antiplatelets, anticoagulation, lipid-lowering Signs/symptoms of stroke/TIA or bleeding, INR,... [Pg.588]

Annexin V is a human placental anticoagulant protein of molecular weight 35kDa that binds to membranes and lipid bilayers containing phosphatidylserine in the presence of free calcium. Annexin V binding to cell surfaces said to result from transmembrane movement of... [Pg.41]

WARNING Co administration w/ ritonavir assoc w/ Hep hepatic decomp w/ fatalities. D/C w/ S/Sxs of H Uses HIV 1 Infxn w/ highly Tx-experienced pts or HIV 1 strains resistant to multiple protease inhibitors. Must be used w/ ritonavir 200 mg Action Antiretroviral HIV-1 protease inhibitor Dose 500 mg PO bid w/ food, administer w/ ritonavir 200 mg PO bid Caution [C, -] Sulfa aU gy, Uvct Dz Contra Mod-severe hepatic insuff concomitant use w/ amiodarone, astemizole, bepridil, cisapride, ergots, flecainide, lovastatin, midazolam, pimozide, propafenone, quinidine, rifampin, simvastatin, terfenadine, triazolam, St. John s wort Disp Caps SE HA, GI distress, rash, fati e, fat redistribution, hyperglycemia, Hep, liver Dz, lipid elevations Interactions T Effects OF anticoagulants, antipits, azole antifun-... [Pg.305]

Uses CAD, hypercholest olemia, hypertriglyceridemia, type 2 DM, arthritis Efficacy No definitive data on X cardiac risk in general population may X lipids and help w/ secondary MI prevention Dose One FDA approved (Lovaza) OTC 1500-3000 mg/d Ammcan Heart Association recommends 1 g/d Caution Mct-cury contamination possible, some studies suggest t cardiac events SE t Bleed risk, dyspqjsia, belching, aftertaste Interactions Anticoagulants EMS t Effects of anticoagulants... [Pg.329]

ANTICOAGULANTS - ORAL Secondary drug Effect LIPID-LOWERING DRUGS Mechanism Precautions... [Pg.398]

The anticoagulant activity of the aortic mucopolysaccharides and the associated ability to stimulate the production of lipid-clearing activity are considered (G7) to be of significance in the development and progression of atherosclerosis. Immunoelectrophoresis has been employed to demonstrate (G4) that one part of the lipids in sclerotic aortic intima is identical with plasma P-lipoprotein. The deposition of plasma P-Iipopro-teins may be associated with the ability of some specific mucopolysaccharide of sclerotic aortic intima to bind p-lipoprotein. [Pg.217]

Lipid-lowering drugs. Fibrates, and some statins, enhance anticoagulant effect. Colestyramine is best avoided for it may impair the absorption of both warfarin and vitamin K. [Pg.572]

See other pages where Lipids anticoagulant is mentioned: [Pg.192]    [Pg.40]    [Pg.192]    [Pg.40]    [Pg.195]    [Pg.898]    [Pg.61]    [Pg.40]    [Pg.40]    [Pg.7]    [Pg.160]    [Pg.331]    [Pg.19]    [Pg.1263]    [Pg.79]    [Pg.160]    [Pg.240]    [Pg.305]    [Pg.331]    [Pg.6]    [Pg.20]    [Pg.315]    [Pg.607]    [Pg.337]    [Pg.369]    [Pg.430]    [Pg.431]    [Pg.437]    [Pg.483]    [Pg.8]    [Pg.251]    [Pg.188]    [Pg.234]    [Pg.181]    [Pg.277]    [Pg.211]    [Pg.212]    [Pg.142]    [Pg.2709]    [Pg.254]    [Pg.123]    [Pg.128]   
See also in sourсe #XX -- [ Pg.18 , Pg.19 , Pg.20 , Pg.21 , Pg.22 , Pg.23 ]



SEARCH



Anticoagulants

Anticoagulation

© 2024 chempedia.info